Patent · US Active

Nanoparticulate megestrol formulations

US9101540B2 · kind B2 · utility

1Cited by
82References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 2004
Grant dateAug 11, 2015
Priority date
Expiry dateSep 1, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.